| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
4,521 |
3,866 |
$197K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
4,443 |
3,755 |
$108K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,539 |
3,472 |
$61K |
| 80061 |
Lipid panel |
3,599 |
3,532 |
$50K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,663 |
5,290 |
$45K |
| 80053 |
Comprehensive metabolic panel |
3,311 |
3,165 |
$36K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
821 |
801 |
$25K |
| 81001 |
|
4,597 |
4,455 |
$15K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,389 |
1,364 |
$14K |
| 82274 |
|
706 |
688 |
$12K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
942 |
909 |
$8K |
| 86769 |
|
309 |
281 |
$7K |
| 36415 |
Collection of venous blood by venipuncture |
643 |
574 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
277 |
136 |
$3K |
| 82570 |
|
581 |
572 |
$3K |
| 84153 |
|
159 |
154 |
$3K |
| 82043 |
|
475 |
471 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
51 |
49 |
$3K |
| 86328 |
|
122 |
117 |
$2K |
| 86701 |
|
194 |
189 |
$2K |
| 86738 |
|
115 |
114 |
$2K |
| 82607 |
|
78 |
77 |
$1K |
| 84439 |
|
97 |
92 |
$941.52 |
| 87088 |
|
108 |
106 |
$924.60 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
92 |
90 |
$768.13 |
| 85651 |
|
195 |
185 |
$701.29 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
15 |
13 |
$694.01 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
15 |
13 |
$686.25 |
| 86592 |
|
84 |
79 |
$363.48 |
| 82947 |
|
43 |
43 |
$150.97 |
| 85730 |
|
15 |
14 |
$95.42 |
| 84436 |
|
16 |
13 |
$94.77 |
| 85610 |
|
15 |
14 |
$63.27 |
| 87177 |
|
12 |
12 |
$59.16 |